ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.7884
0.37%
Brent Oil
80.585
-0.04%
Bitcoin
94,020.38
-0.50%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Kumba Iron Ore Ltd (PK) (KUMBF) Cotización

Kumba Iron Ore Ltd (PK)

Kumba Iron Ore Ltd (PK) (KUMBF)

USOTC
24.045
0.00
(0.00%)
Cerrado 12 Enero 3:00PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
24.045
Postura de Compra
16.20
Postura de Venta
18.94
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
23.52 Rango de 52 semanas 30.00
Capitalización de Mercado [m]
7.716B
Precio Anterior
24.045
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
320,917,362
Rendimiento del Dividendo
3,424.20%
Ratio Precio/Utilidad
0.34
Beneficio por acción (BPA)
70.81
turnover
87.97B
Beneficio neto
22.73B

Acerca de Kumba Iron Ore Ltd (PK)

Sector
Iron Ores
Industria
Iron Ores
Sitio web
www.angloamericankumba.com
Sede
Johannesburg, Gauteng, Zaf
Fundado
-
Kumba Iron Ore Ltd (PK) is listed in the Iron Ores sector of the OTCMarkets with ticker KUMBF. The last closing price for Kumba Iron Ore (PK) was US$24.05. Over the last year, Kumba Iron Ore (PK) shares have traded in a share price range of US$ 23.52 to US$ 30.00.

Kumba Iron Ore (PK) currently has 320,917,362 shares in issue. The market capitalisation of Kumba Iron Ore (PK) is US$7.72 billion. Kumba Iron Ore (PK) has a price to earnings ratio (PE ratio) of 0.34.

KUMBF Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260024.04524.04524.04500CS
52-5.955-19.85303023.528024.92022528CS
156-9.505-28.330849478433.5544.222.7825628.84552946CS
2601.4456.3938053097322.646.928822.623129.30435497CS

KUMBF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Kumba Iron Ore (PK)?
El precio actual de las acciones de Kumba Iron Ore (PK) es US$ 24.045
¿Cuántas acciones de Kumba Iron Ore (PK) están en circulación?
Kumba Iron Ore (PK) tiene 320,917,362 acciones en circulación
¿Cuál es la capitalización de mercado de Kumba Iron Ore (PK)?
La capitalización de mercado de Kumba Iron Ore (PK) es USD 7.72B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Kumba Iron Ore (PK)?
Kumba Iron Ore (PK) ha negociado en un rango de US$ 23.52 a US$ 30.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Kumba Iron Ore (PK)?
El ratio precio/beneficio de Kumba Iron Ore (PK) es 0.34
¿Cuál es el ratio de efectivo a ventas de Kumba Iron Ore (PK)?
El ratio de efectivo a ventas de Kumba Iron Ore (PK) es 0.09
¿Cuál es la moneda de reporte de Kumba Iron Ore (PK)?
Kumba Iron Ore (PK) presenta sus resultados financieros en ZAR
¿Cuál es el último ingresos anual de Kumba Iron Ore (PK)?
El último ingresos anual de Kumba Iron Ore (PK) es ZAR 87.97B
¿Cuál es el último beneficio anual de Kumba Iron Ore (PK)?
El último beneficio anual de Kumba Iron Ore (PK) es ZAR 22.73B
¿Cuál es la dirección registrada de Kumba Iron Ore (PK)?
La dirección registrada de Kumba Iron Ore (PK) es 144 OXFORD ROAD, ROSEBANK, MELROSE, JOHANNESBURG, GAUTENG, 2196
¿Cuál es la dirección del sitio web de Kumba Iron Ore (PK)?
La dirección del sitio web de Kumba Iron Ore (PK) es www.angloamericankumba.com
¿En qué sector industrial opera Kumba Iron Ore (PK)?
Kumba Iron Ore (PK) opera en el sector IRON ORES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discusión

Ver feed completo
gfp927z gfp927z 6 minutos hace
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 7 minutos hace
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 7 minutos hace
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 8 minutos hace
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 11 minutos hace
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 11 minutos hace
We know who you are!
AVXL
gfp927z gfp927z 11 minutos hace
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 11 minutos hace
We know who you are!
AVXL
gfp927z gfp927z 12 minutos hace
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 14 minutos hace
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 15 minutos hace
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 16 minutos hace
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 17 minutos hace
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 20 minutos hace
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 22 minutos hace
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 22 minutos hace
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 23 minutos hace
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 23 minutos hace
Thanks.
RDAR
commdude commdude 24 minutos hace
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 26 minutos hace
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 29 minutos hace
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL
axelvento axelvento 29 minutos hace
Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine
MRNA
Oleblue Oleblue 30 minutos hace
D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a
QBTS
fuagf fuagf 30 minutos hace
You have to be right, when it comes to money and power Musk has everything Trump wants. Wondering what Bannon could have up his sleeve, going out on a limb about keeping Musk out of the White House as he did. Just fell asleep for some two hours. Good break, but always feel lousy after.

Su Consulta Reciente

USOTC
KUMBF
Kumba Iron Ore (PK)
USOTC
POLBF
Poolbeg Pharma (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados